In summary, these observations in mouse models and direct examination of humans with prodromal PD leads us to hypothesize that the disease begins with activation of α-synuclein reactive T cells in the gut, perhaps related to the known microbiome dysbiosis in PD patients, leading to aggregation of α-synuclein in the intestines. This evidence concerns the gene SNCA and Parkinson disease.